These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6427362)

  • 21. Phagocytosis and antimicrobicidal activity of polymorphonuclear leucocytes against gentamicin-sensitive and resistant strains of Pseudomonas aeruginosa.
    Lianou PE; Bassaris HP; Papadimitriou CS; Legakis NJ; Papavassiliou JT
    J Infect; 1983 Jul; 7(1):46-50. PubMed ID: 6415176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
    Perea EJ; Palomares JC; García-Iglesias MC
    Chemotherapy; 1980; 26(4):282-8. PubMed ID: 6248300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
    Milatovic D
    Eur J Clin Microbiol; 1984 Aug; 3(4):288-93. PubMed ID: 6436020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes.
    Hammer MC; Baltch AL; Sutphen NT; Smith RP; Conroy JV
    J Lab Clin Med; 1981 Dec; 98(6):938-48. PubMed ID: 6796635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Thabaut A; Durosoir JL; Meyran M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
    Duval J; Soussy CJ
    Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Philippon A
    Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].
    Knothe H
    Arzneimittelforschung; 1979; 29(12a):1916-20. PubMed ID: 120745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytes.
    Alhede M; Lorenz M; Fritz BG; Jensen PØ; Ring HC; Bay L; Bjarnsholt T
    Med Microbiol Immunol; 2020 Dec; 209(6):669-680. PubMed ID: 32880037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human granulocyte activity against moxalactam-induced filamentous forms of Pseudomonas aeruginosa.
    Hammer MC; Baltch AL; Smith RP; Conroy JV; Bishop M; Michelsen P; Hill L
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1565-70. PubMed ID: 2461161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of antibiotic sensitivities of gram-negative bacilli (comparison of single-disc and inocula-replicating methods).
    Klastersky J; Debusscher L; Cappel R; Swings G; Daneau D
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):391-4. PubMed ID: 4327597
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of Pseudomonas aeruginosa on phagocytosis and killing of rabbit polymorphonuclear leukocytes.
    Kamimura T; Mine Y; Nonoyama S; Nishida M; Goto S; Kuwahara S
    Infect Immun; 1980 Jul; 29(1):13-6. PubMed ID: 6772574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Pseudomonas aeruginosa cytotoxin on human serum and granulocytes and their microbicidal, phagocytic, and chemotactic functions.
    Baltch AL; Hammer MC; Smith RP; Obrig TG; Conroy JV; Bishop MB; Egy MA; Lutz F
    Infect Immun; 1985 May; 48(2):498-506. PubMed ID: 3921465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of cefepime on adhesion and phagocytosis of Pseudomonas aeruginosa].
    Conejo MC; Pascual A; Suárez AI; Perea EJ
    Enferm Infecc Microbiol Clin; 1992 Dec; 10(10):587-91. PubMed ID: 1337979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.